文献速递血脂与心血管预防

罕见SCARB1突变与高密度脂蛋白胆固醇相关但不与冠心病相关

Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease.
PubMed 文献 · Eur Heart J · 2018-01-01

在冰岛人群中,研究鉴定出13个SCARB1编码突变,其中3个罕见突变(p.G319V、p.V111M、p.V32M)与HDL-C升高相关,但在36 886例冠心病患者和306 268例对照中未发现与冠心病风险相关。三个常见非编码变异和一个低频编码变异(p.V135I)也与HDL-C升高相关,同样不增加冠心病风险。结论提示SR-BI功能受损所致HDL-C升高并非冠心病风险标志。

要点

  • SCARB1罕见突变p.G319V、p.V111M、p.V32M与HDL-C升高相关,但不与冠心病风险相关。
  • 常见非编码变异rs61941676-C等与HDL-C升高相关,亦不增加冠心病风险。
  • SR-BI功能受损所致HDL-C升高可能不是冠心病的独立风险标志。

核心结论

  • 因SR-BI功能遗传性受损导致的高HDL-C不是冠心病风险的标志。

研究设计与样本

  • 在相对同质的冰岛人群中,利用全基因组测序资源鉴定SCARB1编码突变,并与HDL-C及冠心病进行关联分析。

主要发现

  • 三个罕见SCARB1突变(p.G319V、p.V111M、p.V32M,合并等位基因频率0.2%)与HDL-C升高相关(p.G319V:β=11.1 mg/dL,P=8.0×10-7;p.V111M:β=8.3 mg/dL,P=1.1×10-6;p.V32M:β=10.2 mg/dL,P=8.1×10-4)。
  • 这些突变与冠心病无关联(36 886例病例/306 268例对照,OR=0.90,95%CI 0.67-1.22,P=0.49)。
  • 三个常见SCARB1非编码变异(包括rs61941676-C:β=1.25 mg/dL,P=1.7×10-18)和一个低频编码变异(p.V135I)与HDL-C升高相关,但不增加冠心病风险。

关键数值与推荐

  • HDL-C关联分析样本量n=136 672。
  • 冠心病关联分析样本量:36 886例病例和306 268例对照。
  • 罕见突变合并等位基因频率=0.2%。

临床怎么用

  • 临床解读HDL-C升高时,不应仅凭SR-BI功能受损相关基因变异判断冠心病风险增加。

局限性

  • 研究人群为冰岛人群,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Scavenger receptor Class B Type 1 (SR-BI) is a major receptor for high-density lipoprotein (HDL) that promotes hepatic uptake of cholesterol from HDL. A rare mutation p.P376L, in the gene encoding SR-BI, SCARB1, was recently reported to associate with elevated HDL cholesterol (HDL-C) and increased risk of coronary artery disease (CAD), suggesting that increased HDL-C caused by SR-BI impairment might be an independent marker of cardiovascular risk. We tested the hypothesis that alleles in or close to SCARB1 that associate with elevated levels of HDL-C also associate with increased risk of CAD in the relatively homogeneous population of Iceland. METHODS AND RESULTS: Using a large resource of whole-genome sequenced Icelanders, we identified thirteen SCARB1 coding mutations that we examined for association with HDL-C (n = 136 672). Three rare SCARB1 mutations, encoding p.G319V, p.V111M, and p.V32M (combined allelic frequency = 0.2%) associate with elevated levels of HDL-C (p.G319V: β = 11.1 mg/dL, P = 8.0 × 10-7; p.V111M: β = 8.3 mg/dL, P = 1.1 × 10-6; p.V32M: β = 10.2 mg/dL, P = 8.1 × 10-4). These mutations do not associate with CAD (36 886 cases/306 268 controls) (odds ratio = 0.90, 95% confidence interval 0.67-1.22, P = 0.49), despite effects on HDL-C comparable to that reported for p.P376L, both in terms of direction and magnitude. Furthermore, HDL-C raising alleles of three common SCARB1 non-coding variants, including one previously unreported (rs61941676-C: β = 1.25 mg/dL, P = 1.7 × 10-18), and of one low frequency coding variant (p.V135I) that independently associate with higher HDL-C, do not confer increased risk of CAD. CONCLUSION: Elevated HDL-C due to genetically compromised SR-BI function is not a marker of CAD risk.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Helgadottir A, Sulem P, Thorgeirsson G, et al. Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease. Eur Heart J. 2018. PMID: 29596577. doi:10.1093/eurheartj/ehy169

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。